Firefly Luciferase K562 Cell Line

Catalog #
78621
$1,900 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant K562 cells constitutively expressing firefly (Photinus pyralis) luciferase under the control of a CMV promoter.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Product Info
Storage and Usage
Citations
Host Cell Line
K562, a human myelogenous leukemia cell line derived from a patient with CML; suspension.
Supplied As
Each vial contains 2 x 106 cells in 1 ml of 10% DMSO
Materials Required But Not Supplied
Name Ordering Information
Thaw Medium 2 BPS Bioscience #60184
Growth Medium 2D BPS Bioscience #79639
96-well Tissue Culture-treated White Clear-bottom Assay Plate Corning #3610
ONE-Step™ Luciferase Assay System BPS Bioscience #60690
Luminometer  
Formulation

For best results, it is highly recommended to use these validated and optimized media from BPS Bioscience. Other preparations or formulations of media may result in suboptimal performance. 

Thaw Medium 2 (BPS Bioscience #60184):
RPMI1640 medium supplemented with 10% FBS, 1% Penicillin/Streptomycin.

Growth Medium 2D (BPS Bioscience #79639):
RPMI1640 medium supplemented with 10% FBS, 1% Penicillin/Streptomycin plus 200 μg/ml of Hygromycin B.

Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

Background

The K562 cell line was established from a patient with chronic myelogenous leukemia (CML) in terminal blast crisis. The Firefly Luciferase K562 Cell Line does not express antigens CD19, CD20 or CD22, therefore it makes an excellent negative control in assays that measure specific killing by CAR-T cells targeting B cell antigens CD19, CD20, and CD22. It can also be used as a highly sensitive in vitro target for the natural killer assay.  The signal generated by the firefly luciferase reporter is proportional to cell numbers.